Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032811 · ClinicalTrials.gov registry record
Pilot Study Of Primary And Secondary Attention-Deficit/Hyperactivity Disorder Among Survivors Of Childhood Cancer
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 100
- Enrollment target
NCT01032811 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 100 participants.
The verdict
NCT01032811 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a pilot study that will be an exploratory investigation of the rate of occurrence of ADHD/S-ADHD in adolescent cancer survivors. The procedures that will be used for identifying attention problem symptoms, determining the frequency and severity of such symptoms, and characterizing the level of impairment resulting from the symptoms are novel to pediatric oncology research.This pilot study will draw from the approach used in traumatic brain injury research of post-injury effects to illuminate more clearly the nature of attentional late effects experienced by survivors of childhood cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01032811
The ClinicalTrials.gov registry entry for NCT01032811 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01032811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01032811 about?
NCT01032811 is a clinical study titled "Pilot Study Of Primary And Secondary Attention-Deficit/Hyperactivity Disorder Among Survivors Of Childhood Cancer". This is a pilot study that will be an exploratory investigation of the rate of occurrence of ADHD/S-ADHD in adolescent cancer survivors. The procedures that will be used for identifying attention problem symptoms, determining the frequency and severity of such symptoms, and characterizing the level ...
What is the current status of trial NCT01032811?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-10. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT01032811?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.